Skip to main content

Enhancer-promoter activation by the Kaposi sarcoma-associated herpesvirus episome maintenance protein LANA


AUTHORS

Ye XXiang , Guerin LNLindsey N , Chen ZZiche , Rajendren SSuba , Dunker WWilliam , Zhao YYang , Zhang RRuilin , Hodges EEmily , Karijolich JJohn . Cell reports. 2024 02 27; 43(3). 113888

ABSTRACT

Higher-order genome structure influences the transcriptional regulation of cellular genes through the juxtaposition of regulatory elements, such as enhancers, close to promoters of target genes. While enhancer activation has emerged as an important facet of Kaposi sarcoma-associated herpesvirus (KSHV) biology, the mechanisms controlling enhancer-target gene expression remain obscure. Here, we discover that the KSHV genome tethering protein latency-associated nuclear antigen (LANA) potentiates enhancer-target gene expression in primary effusion lymphoma (PEL), a highly aggressive B cell lymphoma causally associated with KSHV. Genome-wide analyses demonstrate increased levels of enhancer RNA transcription as well as activating chromatin marks at LANA-bound enhancers. 3D genome conformation analyses identified genes critical for latency and tumorigenesis as targets of LANA-occupied enhancers, and LANA depletion results in their downregulation. These findings reveal a mechanism in enhancer-gene coordination and describe a role through which the main KSHV tethering protein regulates essential gene expression in PEL.